Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
Appointment of Director
Dolby Laboratories, Inc. (the "Company") announces that the Board of Directors
(the "Board") of the Company has appointed Emily Rollins to the Board, effective
as of February 24, 2021, to serve until the Company's 2022 annual meeting of
stockholders or until her successor is duly elected and qualified. On
February 25, 2021, the Company issued a press release announcing the
appointment, the full text of which is filed as Exhibit 99.1 and incorporated
herein by reference.
Ms. Rollins served in various positions at Deloitte & Touche LLP since 1992,
including as an Audit and Assurance Partner from 2006 until her retirement in
September 2020. At Deloitte, Ms. Rollins served technology and media companies
and guided hundreds of clients through complex audit and reporting processes.
Ms. Rollins also served in positions of increasing responsibility, including
leadership roles in Deloitte's US Technology, Media, and Telecommunications
industry group, Audit Innovation and Transformation, and Diversity and
Inclusion. She led firmwide initiatives to recruit, develop, and retain women
and diverse professionals as well as transform and modernize Deloitte's audit
platform. Ms. Rollins currently serves on the boards of several non-profit
entities and associations. Ms. Rollins is a Certified Public Accountant and
holds a B.A. degree in Accounting and International Relations from Claremont
McKenna College.
The Board has affirmatively determined that Ms. Rollins is independent under the
applicable rules and regulations of the Securities and Exchange Commission (the
"SEC") and the listing standards of the New York Stock Exchange.
Ms. Rollins will be compensated for her service on the Board in accordance with
the Company's standard compensation policy for non-employee directors, the terms
of which were described in the section entitled "Compensation of Directors" in
the Company's proxy statement for its 2021 annual meeting of stockholders, filed
with the SEC on December 18, 2020. In addition, Ms. Rollins will enter into the
Company's standard form of indemnification agreement, a copy of which was filed
with the SEC on November 19, 2004 as Exhibit 10.1 to the Company's Registration
Statement on Form S-1 (File No. 333-120614).
There is no arrangement or understanding between Ms. Rollins and any other
persons pursuant to which she was elected as a director. In addition,
Ms. Rollins is not a party to any transaction, or series of transactions,
required to be disclosed pursuant to Item 404(a) of Regulation S-K.
Item 8.01 Other Events.
Disclosure Channels to Disseminate Information
The Company disseminates information to the public about the Company, its
products, services and other matters through various channels, including the
Company's website (www.dolby.com), investor relations website
(http://investor.dolby.com), SEC filings, press releases, public conference
calls and webcasts, in order to achieve broad, non-exclusionary distribution of
information to the public. The Company encourages investors and others to review
the information it makes public through these channels, as such information
could be deemed to be material information.
--------------------------------------------------------------------------------
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
No. Description
99.1 Press Release of Dolby Laboratories, Inc. dated February 25, 2021
104 Cover Page Interactive Data File, formatted in inline XBRL.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses